Novacta Biosystems Ltd.
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Novacta Biosystems Ltd.
Antibiotics charity wants new regimens not just new drugs
Amid mounting concern surrounding antibiotic resistance, charity Antibiotic Research UK says new ideas are needed in this particular research space focused on keeping current drugs in use and not just on creating new products.
The rest is Silence as Christély hands over to Sedgwick
Thomas Christély, who was made CEO of Silence Therapeutics in September 2011 after rising through the executive ranks following his instrumental role in merging the company with Atugen (scripintelligence.com, 20 September 2011), has resigned for personal reasons and given up his place on the board. He will be succeeded by Dr Tony Sedgwick, who also joined Silence in September 2011 as chief business officer. Dr Sedgwick was previously CEO of Novacta Biosystems and chair of Plastid. Dr Georg Buchner, who was brought on board by Dr Sedgwick in October 2011, also from Novacta Biosystems, will take full responsibility for the business development team.
DSM BioSolutions to make Novacta's lantibiotic candidate for tests
DSM BioSolutions has entered into an agreement with Novacta Biosystems of the UK, under which it will manufacture Novacta's lantibiotic candidate for pre-clinical and Phase I clinical trials, as a treatment for Clostridium difficile infection. No financial terms have been disclosed.
Private investment round-up: July 2009
The number of private companies securing investments took a sizeable leap last month, as a number of small financing rounds added to some heavyweight deal making, a Scrip analysis has found.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice